Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange Detected- Version history updated: added revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check38 days agoChange DetectedFooter/revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice as well as Revision: v3.4.1.SummaryDifference0.5%

- Check74 days agoChange DetectedAdded a funding/operational status notice at the top of the page and updated the revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange DetectedAdded a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' field to improve readability and data transparency. The previous 'Last Update Submitted that met QC Criteria' label and the 'No FEAR Act data' text were adjusted, and the page includes a new revision tag 'v3.4.0'.SummaryDifference0.3%

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.